A new skin cancer drug has been developed using a genetically engineered virus that targets and replicates only cancer cells. That's according to public broadcaster NHK who said that researchers in Japan found that 77.8% of those tested, improved.
The experimental drug, created through collaboration between the University of Tokyo and Shinshu University, is part of a growing field known as 'viral therapy,' in which modified viruses are designed to selectively attack cancer cells.
Professor Todo Toshiki of the University of Tokyo and his team conducted trials on patients with an aggressive form of skin cancer to assess whether the treatment could be effective against other types of cancer as well.
Results showed that seven out of nine patients who received a combination of conventional treatment and the viral therapy improved, highlighting the potential of using both approaches together.
With no serious side effects reported so far, researchers plan to test the treatment on another nine patients to further evaluate its safety and efficacy.
Todo said the approach may offer a new option for patients who do not respond to existing treatments.
“If the treatment can be used for a variety of cancers, it could fundamentally change cancer treatment,” he added.
Demonstrators carrying Iranian flags and placards supporting the hijab gathered outside the Azerbaijani Embassy...
A Chinese-made AI chip has matched Nvidia’s H200 in tests conducted by its developer, marking a potential breakthrough in China’s effor...
China’s GJ-21 carrier-based stealth reconnaissance and strike drone has completed its first take-off and landing on board the Sichuan, the co...
The Middle East conflict remains tense as diplomatic efforts continue alongside renewed Houthi attacks. Iran says it remains open to mediation, while the Saudi-led coalition says it intercepted a ballistic missile fired towards the kingdom.
Rescuers searched the wreckage of two high-speed trains in central Spain on Thursday as the death toll rose to a provisional 74, making it the country's second fatal high-speed rail disaster this year.
Evacuations and the provision of humanitarian aid in the Russian-occupied southern Ukrainian town of Oleshky have begun, a senior Ukrainian official said on Friday. In a statement on Telegram, David Arakhamia said a six-day ceasefire was holding, and that more details would follow.
Qatari mediators returned to Tehran on Friday as part of efforts to reach a deal between the U.S. and Iran, according to an official briefed on the talks.
UN human rights experts comprising a group including Special Rapporteurs and independent experts who are part of the UN Human Rights Council, have criticised French authorities over their handling of nationwide student protests.
Visitors to Armenia could face temperature screening after a lab worker died from suspected Pneumonic plague in Russia, Yerevan’s Health Minister Anahit Avanesyan told lawmakers on Wednesday, Armenian state news agency Armenpress reported.
Health advice now reaches people through social media, fitness apps, wearable technology and AI. From detoxes and protein-focused diets to skincare and fitness trends, online wellness content is shaping everyday health choices while raising concerns about misinformation and potential risks.
Global cholera deaths reached their highest annual level in more than 20 years in 2025, despite a decline in reported cases, according to the World Health Organization (WHO).
Chinese researchers have developed the world’s smallest CT scanner, a portable device designed to produce images of tiny fossils and archaeological relics.
Here's your AnewZ Daily Brief for 17 September 2026. These are the top five stories making headlines in the field of health.
You can download the AnewZ application from Play Store and the App Store.
What is your opinion on this topic?
Leave the first comment